Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis

[1]  M. Ando,et al.  Acute exacerbations of fibrotic interstitial lung diseases , 2020, Respirology.

[2]  H. Collard,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation , 2020, European Respiratory Journal.

[3]  Kazuhisa Takahashi,et al.  Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study , 2019, Respiratory Research.

[4]  A. Takise,et al.  Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis , 2019, Medicina.

[5]  Jong Sun Park,et al.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis , 2019, Tuberculosis and respiratory diseases.

[6]  H. Tomioka,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study , 2018, BMJ Open Respiratory Research.

[7]  Y. Kondoh,et al.  Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis. , 2018, Respiratory medicine.

[8]  Takeshi Johkoh,et al.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[9]  Y. Nei,et al.  Clinical Characteristics Based on the New Criteria of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis. , 2018, The Eurasian journal of medicine.

[10]  D. Lynch,et al.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. , 2016, American journal of respiratory and critical care medicine.

[11]  C. Thomson,et al.  Field walking tests in chronic respiratory disease. , 2015, Annals of the American Thoracic Society.

[12]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[13]  A. Wells,et al.  Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.

[14]  H. Collard,et al.  Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials , 2013, Respiratory Research.

[15]  G. Verleden,et al.  The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. , 2013, American journal of respiratory and critical care medicine.

[16]  Charlie Strange,et al.  An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. , 2012, American journal of respiratory and critical care medicine.

[17]  Joyce S Lee,et al.  Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis , 2012, Thorax.

[18]  M. Bhargava,et al.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis , 2012, Reference Module in Biomedical Sciences.

[19]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[20]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[21]  K. Meyer,et al.  The Role of Immunity and Inflammation in Lung Senescence and Susceptibility to Infection in the Elderly , 2010, Seminars in respiratory and critical care medicine.

[22]  Jong-Min Song,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.

[23]  A. Nicholson,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features , 2006, European Respiratory Journal.

[24]  J. Myers,et al.  Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. , 2005, Chest.

[25]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[26]  Katsutoshi Nakayama,et al.  Anticoagulant therapy for idiopathic pulmonary fibrosis. , 2005, Chest.

[27]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[28]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[29]  F. Al-Hameed,et al.  Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. , 2004, Canadian respiratory journal.

[30]  R. Trisolini,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: report of a series , 2003, European Respiratory Journal.

[31]  P. Jolliet,et al.  Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis , 2001, Intensive Care Medicine.

[32]  Okudela Koji,et al.  Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome. , 2019, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[33]  C. Ronco,et al.  Incidence, Risk Factors, and Outcome , 2014 .

[34]  S. Rizvi,et al.  Risk factors and outcome , 2008 .

[35]  Mark C. Wilson,et al.  Asymptotics for Generalized Riordan Arrays , 2005 .